BRUSSELS and ATLANTA, Georgia, May 30 /PRNewswire/ -- The International
Diabetes Federation (IDF) BRIDGES translational research grant programme
will fund a lifestyle intervention trial that seeks to reduce the risk of
for people developing type 2 diabetes in Chennai, India.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080602/306819 )
The community based diabetes prevention programme will determine
optimal ways to translate the programs developed for research studies of
lifestyle interventions for diabetes prevention to real-life settings in
Chennai (formerly Madras) India. The Rollins School of Public Health at
Emory University will collaborate with a team of investigators from Madras
Diabetes Research Foundation (MDRF) and will facilitate a study of 700
people with pre-diabetes in Chennai. The study is designed to explore ways
to identify and evaluate culturally appropriate, low-cost, feasible and
sustainable ways to promote changes in health behaviours, improved diet,
weight loss and increased physical activity to prevent diabetes in those in
South India.
The messages will be tailored to the unique dietary patterns and
physical activity programmes of Indian communities and will be designed to
determine if these targeted interventions are effective and cost-effective.
"This grant will help researchers and clinicians to better understand
how to create and deliver culturally tailored programs for the prevention
of diabetes in high-risk populations. The project is designed to produce a
permanent, community-based program for promoting diabetes prevention and
healthy lifestyle changes" said Dr. K.M. Venkat Narayan, principal
investigator of the study and a world leader in translational research.
The International Diabetes Federation's Diabetes Atlas reports that
India has the highest number of people with diabetes in the world.
Currently, 40.9 million Indians have diabetes and by 2025, this number will
rocket to 69.9 million. In addition, 35 million Indians are at risk for
diabetes -impaired glucose tolerance (IGT). India is not alone in facing
the diabetes epidemic. Over 250 million people worldwide live with diabetes
and by 2025, over 380 million people will have the disease.(1)
"All South Asians, including those with diabetes, could benefit from
making the positive changes in diet, activity, and behaviour that are
taught in this program," said Dr. Narayan.
Data and results from the trial will be used to design and advocate
policy and public health recommendations, which will result in broader
diabetes prevention efforts in India and other South Asian countries.
"India is at the epicentre of the diabetes pandemic. Every effort must
be taken to prevent the devastating human, social and economic effects of
diabetes," said Dr. Linda Siminerio, Chair of the IDF BRIDGES Review
Committee. "The Chennai trial led by Dr. Narayan and Indian investigators
will help to address the major public health issue."
The Federation, through BRIDGES, is committed to converting research
findings into useful practices for the provision of quality care and
services delivered by healthcare providers. The culturally specific
randomized trial in India, along with the 10 other selected translational
research projects, was chosen because of its innovative idea, demonstration
of the potential for health care cost savings, sustainability plans and the
opportunity for its results to be widely replicated in other settings.
The International Diabetes Federation independently manages the
Bringing Research in Diabetes to Global Environments and Systems (BRIDGES)
program with an educational grant from Eli Lilly and Company and is
committed to promoting diabetes care, prevention and a cure worldwide.
Note to editors:
The International Diabetes Federation (IDF) is the global advocate for
the over 250 million people with diabetes worldwide. It represents over 200
diabetes associations in more than 160 countries. Its mission is to promote
diabetes care, prevention and a cure worldwide. The International Diabetes
Federation is an NGO in official relations with the World Health
Organization and an associated NGO with the United Nations Department of
Public Information. The International Diabetes Federation leads the World
Diabetes Day campaign. Additional information is available at
http://www.idf.org.
Bringing Research in Diabetes to Global Environments and Systems
(BRIDGES) is the global translational grant programme of the International
Diabetes Federation. It solicits proposals that support cost effective and
sustainable interventions that can be adopted in real world settings, for
the prevention and control of diabetes. Projects should be based on
interventions already proven to be effective in trials to prevent and treat
diabetes, to improve care of type 1 and type 2 diabetes and delay its
complications. The interventions proposed should have the potential to be
widely disseminated to clinical practice, individuals and communities. For
more information, visit http://www.idfbridges.org.
Founded in 1835, Emory University has grown into a national center for
teaching, research, and service, awarding more than 2,500 undergraduate and
graduate degrees annually. It is recognized as one the top 25 universities
in the United States. The Rollins School of Public Health (RSPH) was
founded in 1991. The mission RSPH is "to improve health and prevent disease
in human populations around the world by acquiring, disseminating and
applying knowledge." For more information, visit http://www.emory.edu.
(1) Diabetes Atlas, 3rd Edition, International Diabetes Federation,
2006.
See Also
- 5 Easy Tips That Make An Effective Workout!
- What To Do Before Starting A Fitness Plan
- Anti Wrinkle Eye Cream
- BeautySchools.edu Premiers New Trends For Summer
Via: Healthcare
0 коментарі:
Post a Comment